Randomized controlled pilot trial of luteal phase recombinant FSH stimulation in poor responders

Reproductive BioMedicine Online

Volumn 17, Issue 6, 2008, Pages 745-750

  Kalra, Suleena Kansal ^a,b   Ratcliffe, Sarah ^a   Gracia, Clarisa R ^a   Martino, Linda ^a   Coutifaris, Christos ^a   Barnhart, Kurt T ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE   (United States)

Author keywords

FSH; GnRH antagonist; IVF; Luteal phase; Poor ovarian response; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GANIRELIX; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; LIVE BIRTH; LUTEAL PHASE; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OPTIMAL DRUG DOSE; OVARY FOLLICLE; OVULATION INDUCTION; POOR OVARIAN RESPONSE; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

EID: 58149094628     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60400-2     Document Type: Article

References (13)

1. Barrenetxea G, Agirregoikoa JA, Jimeniz MR et al. 2008 Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertility and Sterility 89, 546-563.
2. Eskandar M, Jaroudi K, Jambi A et al. 2004 Is recombinant follicle-stimulating hormone more effective in IVF poor responders than human menopausal gonadotrophins? Medical Science Monitor 10, 16-19.
3. Faber BM, Mayer J, Cox B et al. 1998 Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertility and Sterility 69, 826-830.
4. Griesinger G, Diedrich K, Tarlatzis BX et al. 2006 GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analyses. Reproductive BioMedicine Online 13, 628-638.
5. Hall JE, Schoenfeld DA, Martin KA et al. 1992 Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal follicular transition. Journal of Clinical Endocrinology and Metabolism 74, 600-607.
6. Klinkert ER, Broekmans FJ, Looman CW et al. 2005 Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Human Reproduction 20, 611-615.
7. Kucuk T, Sozen E 2007 Luteal start of exogenous FSH in poor responder women. Journal of Assisted Reproductive Genetics 24 635-638.
8. Padilla SL, Dugan K, Maruschak V et al. 1996 Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertility and Sterility 65, 796-799.
9. Rombauts L, Suikkari AM, MacLachlan V et al. 1998 Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertility and Sterility 69, 665-669.
10. Shanbhag S, Aucott L, Bhattacharya S et al. 2007 Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilization (IVF). Cochrane Database of Systematic Reviews, CD004379.
11. Sunkara SK, Tuthill J, Khairy M et al. 2007 Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis. Reproductive BioMedicine Online 15, 539-546.
12. Tartlazis BC, Zepiriedis L, Grimbizis G et al. 2003 Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reproduction Update 9, 61-76.
13. Wang PT, Lee RK, Su JT et al. 2002 Cessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor responders. Journal of Assisted Reproductive Genetics 19, 1-6.